Your Phase 2 Signal Is Only as Good as Your Patient Retention
Patients signal disengagement in their language weeks before they miss a visit.
Canvs reads that signal before it becomes a dropout.
Trusted by Organizations That Understand Patient Experience
25.9%
CNS trial dropout rate - highest of any therapeutic area
$30K-$70K
cost to replace a single dropped Phase 2 patient
80%
of clinical trials fail to meet enrollment timelines
How Biotech Sponsors Win with Canvs
Catch risk before it’s visible
Canvs interprets patient language longitudinally - by cohort, site, and dose arm - so you see disengagement weeks before it shows up in your data.
Protect Phase 2 readouts
Cohort-level disengagement distorts efficacy signal. Canvs flags patterns early enough to act before data integrity is compromised.
Zero workflow disruption
Read-only. No new surveys. No protocol changes. Sits alongside your ePRO and eCOA without touching your regulatory posture.
Engage Audiences &
Drive Impact
Detect engagement risk during the trial
Your patients are already telling you they’re disengaging - in their PRO responses, their diary entries, their open-ended answers. Today that signal gets reduced to a score. Canvs reads the language behind it, across the full trial, before dropout becomes inevitable.
Detect disengagement weeks before missed visits
Compare engagement across sites, cohorts, and dose arms
Every finding traceable to the patient’s own words
Zero changes to trial workflow or protocol
Lead in a Crowded Market
Stand out by understanding your audience better than anyone else.
Anticipate shifts in taste and stay ahead of the curve.
Build lasting loyalty in a crowded, fast-moving landscape.
Drive Growth & Revenue
Optimize campaigns that drive engagement and retention.
Turn audience insights into smarter ad and subscription strategies.
Show clear ROI by connecting audience feedback to business outcomes.
Connect VoC to Business Impact
Unify feedback from surveys, social, and reviews in one platform.
Cut through the noise with fast, AI-driven analysis.
Empower every team with the same insights to act with confidence.
Built for clinical trials.
Not a clinical tool.
What Canvs is:
- A read-only interpretation layer
- Detecting early engagement risk
- Explaining why engagement shifts
- Non-clinical and non-diagnostic
- Fully auditable, source-traceable
What Canvs is not:
- A clinical decision-making tool
- A data collection or ePRO platform
- A safety signal or AE reporting system
- A replacement for validated eCOA instruments
- A regulated medical device or diagnostic
"Canvs AI is a very sophisticated tool that allows us to ask questions, bring insights into meetings, and lead conversations to understand opportunities and challenges."
Connects to where your trial data already lives
Medidata Rave · Veeva Vault · REDCap · ePRO platforms · Survey tools · Enterprise data systems
.svg)
%204.avif)
Backed by Customer Love
20+ More
Compliant By Design. Ready for pharma procurement.
